To evaluate if the expression levels of miR-190, -429 and -584 are different in HER2+ versus normal-like epithelial cells, as predicted by in silico analysis, we performed RT-PCR assay of these three miRNAs in both cell line and human BC samples. The gene discussed is ERBB2; the disease is breast cancer.